These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11127360)

  • 41. Treatment of recurrent attacks of supraventricular tachycardia during pregnancy causing complications in both mother and fetus.
    Rao BS; Maharana P; Jagannath G; Basu SB; Jha BN
    Indian Heart J; 2001; 53(6):785-7. PubMed ID: 11838938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of common arrhythmias: Part I. Supraventricular arrhythmias.
    Hebbar AK; Hueston WJ
    Am Fam Physician; 2002 Jun; 65(12):2479-86. PubMed ID: 12086237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.
    Ting SM; Lee D; Maclean D; Sheerin NS
    Cardiology; 2008; 111(2):83-6. PubMed ID: 18376118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of junctional tachycardia with high doses of flecainide in infants].
    Chantepie A; Moquet B; Cosnay P; Blanchard P; Marchand S; Grenier B; Fauchier JP
    Presse Med; 1988 Sep; 17(31):1587-8. PubMed ID: 2971964
    [No Abstract]   [Full Text] [Related]  

  • 45. Flecainide induced ventricular fibrillation in a neonate.
    Ackland F; Singh R; Thayyil S
    Heart; 2003 Oct; 89(10):1261. PubMed ID: 12975443
    [No Abstract]   [Full Text] [Related]  

  • 46. Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation.
    Husser D; Stridh M; Sornmo L; Geller C; Klein HU; Olsson SB; Bollmann A
    Am J Cardiol; 2005 Feb; 95(4):526-8. PubMed ID: 15695146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. After a long time, the new ESC Guidelines for the management of patients with supraventricular tachycardia are here.
    Tamargo J
    Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):3-5. PubMed ID: 31800023
    [No Abstract]   [Full Text] [Related]  

  • 48. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
    Turner P; Camm AJ; Saunders JP
    Postgrad Med J; 1986 Jan; 62(723):70. PubMed ID: 3099276
    [No Abstract]   [Full Text] [Related]  

  • 50. [Flecainide (Tambocor)--a new anti-arrhythmia agent].
    Wray H; Corbey M
    Tidsskr Nor Laegeforen; 1989 Jan; 109(1):92-4. PubMed ID: 2492125
    [No Abstract]   [Full Text] [Related]  

  • 51. A symposium: The use of encainide in supraventricular tachycardias. June 3 and 4, 1988, Bermuda. Proceedings.
    Am J Cardiol; 1988 Dec; 62(19):1L-84L. PubMed ID: 3144162
    [No Abstract]   [Full Text] [Related]  

  • 52. Use of flecainide in children.
    Till JA; Rowland E; Shinebourne EA
    Lancet; 1989 Aug; 2(8658):326. PubMed ID: 2569119
    [No Abstract]   [Full Text] [Related]  

  • 53. Dangerous recurrence of arrhythmia following withdrawal of flecainide.
    Murdoch IA; Priestley KA; Parsons JM
    Int J Cardiol; 1990 Aug; 28(2):259-60. PubMed ID: 2118487
    [No Abstract]   [Full Text] [Related]  

  • 54. Paroxysmal reciprocating supraventricular tachycardia in infants: electrophysiologically guided medical treatment and long-term evolution of the re-entry circuit.
    Drago F; Silvetti MS; De Santis A; Marcora S; Fazio G; Anaclerio S; Versacci P; Iodice F; Di Ciommo V
    Europace; 2008 May; 10(5):629-35. PubMed ID: 18385122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenosine vs. calcium channel blockers for supraventricular tachycardia.
    Anugwom C; Sulangi S; Dachs R
    Am Fam Physician; 2007 Jun; 75(11):1653-4. PubMed ID: 17575655
    [No Abstract]   [Full Text] [Related]  

  • 56. [Perioperative management of cardiac arrhythmia: part II].
    Zaballos García M; López Berlanga JL; Navia Roque J
    Rev Esp Anestesiol Reanim; 2006 Mar; 53(3):163-83; quiz 183, 193. PubMed ID: 16671260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Protocols for the treatment of supraventricular tachycardias in the fetus].
    Oudijk MA; Ambachtsheer EB; Stoutenbeek P; Meijboom EJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1218-9. PubMed ID: 11447879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New antiarrhythmic drugs. II. Flecainide.
    Schneeweiss A
    Pediatr Cardiol; 1990 Jul; 11(3):143-6. PubMed ID: 2118629
    [No Abstract]   [Full Text] [Related]  

  • 59. [Drug therapy of ventricular arrhythmia].
    Hashiba K
    Nihon Naika Gakkai Zasshi; 1991 Mar; 80(3):447-50. PubMed ID: 1856562
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intravenous flecainide administration for conversion of paroxysmal atrial fibrillation in the emergency room].
    Antonelli D; Feldman A; Freedberg NA; Darawsha A; Rosenfeld T
    Harefuah; 2006 May; 145(5):342-4, 398. PubMed ID: 16805213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.